Randall Rasmusson

Randall Rasmusson is a Professor in the Department of Physiology and Biophysics at the Jacobs School of Medicine & Biomedical Sciences, University at Buffalo. He holds a PhD in Physiology from Duke University (1991) and has held academic roles since 1991, including positions at SUNY, Pennsylvania State University, and Allegheny University of Health Sciences. His research focuses on ion channel biophysics, cardiac electrophysiology, and computational modeling of disease mechanisms.

Research interests include Biomedical Engineering, Biophysical Modeling, Drug Development, and Neuroscience, with a particular emphasis on ion channel kinetics, membrane transport, and stem cell-derived cardiac models. He has contributed to the CiPA initiative for drug safety screening and developed dynamic clamp technologies for real-time electrophysiological analysis.

Key awards include the UB Exceptional Scholar Award (2011) and fellowships from the American Heart Association. His grants include NIH and NSF funding for projects like advanced dynamic clamp systems and HERG ion channel drug interaction analysis. He co-founded Cytocybernetics Inc., a biotech firm advancing drug screening technologies.

Rasmusson’s work integrates computational models with experimental data to study cardiac arrhythmias and autism spectrum disorders. Notable collaborations include studies on Timothy syndrome mouse models and ion channel mutations in cardiac cells.